Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-5-4
pubmed:abstractText
It has been reported that the immunosuppressant rapamycin decreases the viability of pancreatic beta cells. In contrast, exendin-4, an analogue of glucagon-like peptide-1, has been found to inhibit beta cell death and to increase beta cell mass. We investigated the effects of exendin-4 on the cytotoxic effect of rapamycin in beta cells. Incubation with 10 nM rapamycin induced cell death in 12 h in murine beta cell line MIN6 cells and Wistar rat islets, but not when coincubated with 10 nM exendin-4. Rapamycin was found to increase phosphorylation of c-Jun amino-terminal kinase (JNK) and p38 in 30 minutes in MIN6 cells and Wistar rat islets while exendin-4 decreased their phosphorylation. Akt and extracellular signal-regulated kinase (ERK) were not involved in the cytoprotective effect of exendin-4. These results indicate that exendin-4 may exert its protective effect against rapamycin-induced cell death in pancreatic beta cells by inhibiting JNK and p38 signaling.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP-Dependent Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP..., http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 4, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/Venoms, http://linkedlifedata.com/resource/pubmed/chemical/exenatide, http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1439-4286
pubmed:author
pubmed:copyrightInfo
Georg Thieme Verlag KG Stuttgart-New York.
pubmed:issnType
Electronic
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
311-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20213584-Animals, pubmed-meshheading:20213584-Antibiotics, Antineoplastic, pubmed-meshheading:20213584-Blotting, Western, pubmed-meshheading:20213584-Cell Death, pubmed-meshheading:20213584-Cell Survival, pubmed-meshheading:20213584-Culture Media, pubmed-meshheading:20213584-Cyclic AMP-Dependent Protein Kinases, pubmed-meshheading:20213584-Dose-Response Relationship, Drug, pubmed-meshheading:20213584-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:20213584-Flow Cytometry, pubmed-meshheading:20213584-Insulin, pubmed-meshheading:20213584-Insulin-Secreting Cells, pubmed-meshheading:20213584-Islets of Langerhans, pubmed-meshheading:20213584-MAP Kinase Kinase 4, pubmed-meshheading:20213584-Peptides, pubmed-meshheading:20213584-Phosphatidylinositol 3-Kinases, pubmed-meshheading:20213584-Phosphorylation, pubmed-meshheading:20213584-Rats, pubmed-meshheading:20213584-Rats, Wistar, pubmed-meshheading:20213584-Sirolimus, pubmed-meshheading:20213584-Venoms, pubmed-meshheading:20213584-p38 Mitogen-Activated Protein Kinases
pubmed:year
2010
pubmed:articleTitle
Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation.
pubmed:affiliation
Department of Diabetes and Clinical Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't